Search

Clinical Articles / BY: Rebecca Warburton, MD, FRCSC March 2018
... detrimental to cosmesis.[ 17,18 ] Reoperation occurs in 20% to 30% of BCS cases.[19] Local in-breast recurrence after ... all patients with invasive breast cancer. Axillary lymph node dissection (ALND) has now been replaced by sentinel lymph node biopsy (SLNB) for most patients with clinically ...
Clinical Articles / BY: F. Michelle Sutter, MD, FRCSC March 2018
... is not necessary after mastectomy for DCIS. Invasive node-negative breast cancer   In general, adjuvant ... whole-breast radiation is recommended for patients with node-negative disease who have undergone BCS as this approach ... therapy is delivered in an accelerated fashion over 16 to 20 sessions. Depending on patient factors such as large ...
Clinical Articles / BY: Connie G. Chiu, MD, FRCSC March 2018
... The estimated risk for patients undergoing axillary lymph node dissection (ALND) is 20%, compared with 5% for sentinel lymph node biopsy (SLNB).[ 1 ] However, a more clinically ...
Clinical Articles / BY: Christine E. Simmons, MD, MSc, FRCPC March 2018
... largely accepted as the standard of care in patients with node-positive or high-risk node-negative breast cancer.[ 3 ] Currently, guidelines ... ER-positive and HER2-negative, 35% were HER2-positive, and 20% were triple-negative. While there has been a trend toward ...
Editorials / BY: Rona E. Cheifetz, MD, MEd, FRCSC, FACS March 2018
... a greater range of reconstructive options. Axillary lymph node surgery has also evolved, with sentinel lymph node biopsy being recommended for most patients with a ... an improvement in outcomes for breast cancer over the past 20 years with more individualized and multimodal treatment ...